Clinical Trial Update: Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

Clinical trial update: a Phase 2 study of methotrexate plus dipyridamole in advanced ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Dipyridamole (Dipyridamole)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Ottawa Regional Cancer Centre | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN